The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Oxford AHSN develops the business case for cobas® Liat® influenza test and wins Near Patient Testing award at the UK Diagnostics Summit
The cobas® Liat® System is a fast, easy-to-use, compact PCR system designed for on-demand testing in point-of-care settings such as clinics, pharmacies, and hospital and satellite laboratories. The Oxford AHSN assisted in the first UK based evaluation of the the cobas® Liat® Influenza A/B test, in the Emergency Department (ED) of the Royal Berkshire Hospital, which provides secondary emergency care for most of Berkshire. The test is a PCR based test using either nasopharyngeal or throat swabs and requires minimal sample preparation. The evaluation aimed to see if the test reduced patient length of stay, reduced antibiotic use and increased the use of antivirals. The Oxford AHSN project managed the evaluation and provided active, hands-on support. The Oxford AHSN also enlisted York Health Economics Consortium (YHEC) to provide impartial health economics, using the metrics collected during the evaluation and anonymised data. The health economic data was then used to inform the business case for the Trust procuring the tests going forward. Plans to roll out the test in community settings have been put on hold pending a product update to include a Covid-19 test.
Smart with your heart
Smart with your Heart aims to reduce readmissions in heart failure pathways by using digital technology. The aim was to reduce the 'revolving readmission door' for heart failure patients, by working in partnership with secondary and primary care settings and 3 digital providers.
Thousands more pregnant women benefit from test to rule out pre-eclampsia following national rollout led by AHSNs
Quick, accurate blood tests which can help rule out pre-eclampsia are improving care for pregnant women and their unborn babies, reducing anxiety and saving the NHS money. AHSNs are leading a rapid adoption project for these tests into maternity units across the country.
Quicker stroke care and reduced costs
New artificial intelligence (AI)-driven imaging support software which has the potential to deliver huge benefits to hundreds of stroke patients each year and significant cost savings to the NHS has been implemented at the Royal Berkshire NHS Foundation Trust (RBH). The Oxford AHSN is supporting wider regional roll-out backed by NHS England. The CE-marked e-Stroke Suite developed by Brainomix Ltd includes tools for non-contrast CT and CT angiography brain scans, connecting physicians and facilitating information transfer. The software supports physicians in identifying patients who would benefit from acute stroke treatments, selecting patients most likely to benefit from specific interventions, such as mechanical thrombectomy.
Consortium including Oxford AHSN and POCKiT Diagnostics secures over £700,000 in grant funding to improve diagnosis of stroke within the NHS in England
Stroke affects 100,000 people in the UK each year . 33% of patients will die and 90% of survivors will have a disability for the rest of their lives.
PAD and PAWS: Peripheral Arterial Disease and Prevention, Assessment, Wound management, Self-care
This service improvement programme aims to enable primary care staff to improve lower limb vascular assessments in patients with leg ulcers to allow appropriate treatment to start earlier.
Youth Empowerment Skills (YES) for teenagers with Type 1 diabetes
Guy’s and St Thomas’ YES programme gives 14-19 year-olds in south London the support they need to live with Type 1 diabetes. Participants meet other young people with Type 1 diabetes, building confidence and developing a peer support network. Learn how the Health Innovation Network (HIN) supported the programme to scale up from one London borough to twelve.
Supporting remote monitoring in an outpatient setting
We are supporting three rheumatology departments across south east London (SEL) to trial a new service that supports patients with rheumatoid arthritis (RA) to remotely monitor their condition. The service aims to help people access the care they need, when they most need it, rather than rely on routine appointments.
RefuAid is a charity that sources and supports refugee healthcare professionals to work in the NHS.www.refuaid.org
Safer medicine administration in care homes during Covid-19
The HIN engaged with OPUS and commissioned them on a pro bono basis to adapt their existing comprehensive guidance to ensure care home staff were aware of how to safely administer medicines without using a dosette box during the pandemic.
Compass Point of Care AKI & HAP App
A registered clinical device, the Compass Point of Care AKI & HAP app is a tool providing augmented intelligence in the form of decision support algorithms to support the early intervention and prevention of acute kidney injury (AKI) and hospital-acquired pneumonia. Use of this app is proven by published clinical trials and real-world use within NHS and international healthcare systems to reduce both conditions in hospitals by up to 60%. The app delivers benefits to both COVID and non-COVID patients and is available to download for IOS and Android devices.
Gendius developed product Intellin® is an intelligent diabetes management platform that uses clinical data to predict the trajectory of an individual's diabetes and helps to mitigate progression through smart tips. Powered by sophisticated AI algorithms, Intellin® is changing the way diabetes is managed. The Intellin® App is today the fastest downloaded diabetes app in the world.